Carbiotix AB (publ) (NGM:CRBX)

Sweden flag Sweden · Delayed Price · Currency is SEK
6.58
+0.82 (14.24%)
At close: Dec 15, 2025
-21.67%
Market Cap 32.74M
Revenue (ttm) 2.31M
Net Income (ttm) -14.46M
Shares Out 4.98M
EPS (ttm) -3.10
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 19,438
Average Volume 8,055
Open 6.20
Previous Close 5.76
Day's Range 4.90 - 6.98
52-Week Range 3.70 - 14.75
Beta 0.11
RSI 54.78
Earnings Date Feb 13, 2026

About Carbiotix AB

Carbiotix AB (publ), a biotechnology company, develops health testing and microbiome modulators to address a range of chronic and metabolic diseases. Its portfolio includes prebiotic ingredients and diagnostic testing services. The company develops a prebiotic soluble fiber based on virgin and upcycled natural substrates containing arabinoxylo-oligosaccharides; and LinkGut, a health test. Carbiotix AB (publ) was incorporated in 2014 and is headquartered in Lund, Sweden. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2014
Employees 9
Stock Exchange Nordic Growth Market
Ticker Symbol CRBX
Full Company Profile

Financial Performance

In 2024, Carbiotix AB's revenue was 2.86 million, a decrease of -33.38% compared to the previous year's 4.29 million. Losses were -16.13 million, 19.7% more than in 2023.

Financial Statements

News

There is no news available yet.